Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region

This publication has 65 references indexed in Scilit:

• Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials
  Current Medicinal Chemistry, 2006
• An integrated epigenetic and genetic approach to common human disease
  Trends in Genetics, 2004
• Modern Criteria to Establish Human Cancer Etiology
  Cancer Research, 2004
• Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome
  Molecular Cancer, 2003
• Papillomaviruses and cancer: from basic studies to clinical application
  Nature Reviews Cancer, 2002
• Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer
  BMC Cancer, 2002
• DNA methylation of nuclear receptor genes—possible role in malignancy
  The Journal of Steroid Biochemistry and Molecular Biology, 2002
• The promise of retinoids to fight against cancer
  Nature Reviews Cancer, 2001
• Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
  Oncogene, 1999
• RARβ2-Mediated Growth Inhibition in HeLa Cells
  Experimental Cell Research, 1996